Abstract
Objectives
To evaluate the staging accuracy of magnetic resonance imaging (MRI) for endometrial cancer in daily practice over a 3-year period at a tertiary referral centre receiving scans from a large number of hospitals with varying protocols. To compare these daily practice results to published data from single-centre studies.
Methods
After ethical approval, MRI staging records for 270 studies from nine network and three centre hospitals were retrospectively collected and compared with final operative histopathology. The International Federation of Gynaecology and Obstetrics (FIGO) stage, depth of invasion assessment and cervical stromal invasion were analysed and reasons for discrepancies reviewed.
Results
MRI-based complete FIGO stage was fully concordant with histopathology in 65.6%. MRI accuracy for depth of myometrial invasion and cervical stromal invasion was 73.3% and 89.3% respectively. Our results did not match the high accuracy previously reported in studies based on single centres.
Conclusions
Published MRI staging accuracy from small single-centre studies were not replicated in a tertiary referral centre receiving scans with heterogeneous protocols over a 3-year period. These results highlight the challenges faced in daily practice and may reflect achievable and realistic MRI staging accuracies in large rapid throughput referral networks. Adherence to standardised high-quality protocols may help to improve future results.
Key Points
• Three-year MRI-staging accuracy for endometrial cancer in a multicentre cancer network
• Daily practice MRI-staging accuracy did not meet results of single-centre studies
• Large scale cancer network MRI-staging accuracies should be further evaluated
• Treatment recommendations should be based on achievable MRI-staging accuracies
Similar content being viewed by others
Abbreviations
- DCE:
-
Dynamic contrast enhancement
- DWI:
-
Diffusion weighted imaging
- EC:
-
Endometrial carcinoma
- FIGO:
-
International Federation of Gynaecology and Obstetrics
- MDTM:
-
Multi-disciplinary team meeting
- MRI:
-
Magnetic resonance imaging
- T1W:
-
T1-weighted
- T2W:
-
T2-weighted
References
U.S. Cancer Statistics Working Group DoHaHS, Centers for Disease Control and Prevention, and National Cancer Institute (2016) United States Cancer Statistics: 1999–2013 Incidence and Mortality Web-based Report. Department of Health and Human Services, Centers for Disease Control and Prevention, and National Cancer Institute, Atlanta, USA. Available via: www.cdc.gov/uscs
Cancer Research UK (2017) Cancer statistics. Available via: www.cancerresearchuk.org/health-professional/cancerstatistics/statistics-by-cancer-type/uterine-cancer#heading-Zero. Accessed September 2017
Amant F, Mirza MR, Creutzberg CL (2012) Cancer of the corpus uteri. Int J Gynaecol Obstet 119:S110–S117
Colombo N, Creutzberg C, Amant F et al (2016) ESMO-ESGO-ESTRO Consensus Conference on Endometrial Cancer: diagnosis, treatment and follow-up. Int J Gynecol Cancer 26:2–30
Patel S, Liyanage SH, Sahdev A, Rockall AG, Reznek RH (2010) Imaging of endometrial and cervical cancer. Insights Imaging 1:309–328
Beddy P, Moyle P, Kataoka M et al (2012) Evaluation of depth of myometrial invasion and overall staging in endometrial cancer: comparison of diffusion-weighted and dynamic contrast-enhanced MR imaging. Radiology 262:530–537
Sala E, Rockall AG, Freeman SJ, Mitchell DG, Reinhold C (2013) The added role of MR imaging in treatment stratification of patients with gynecologic malignancies: what the radiologist needs to know. Radiology 266:717–740
AlHilli MM, Mariani A (2013) The role of para-aortic lymphadenectomy in endometrial cancer. Int J Clin Oncol 18:193–199
Kondalsamy-Chennakesavan S, van Vugt S, Sanday K et al (2010) Evaluation of tumor-free distance and depth of myometrial invasion as prognostic factors for lymph node metastases in endometrial cancer. Int J Gynecol Cancer 20:1217–1221
Sala E, Wakely S, Senior E, Lomas D (2007) MRI of malignant neoplasms of the uterine corpus and cervix. AJR Am J Roentgenol 188:1577–1587
Spencer JA, Messiou C, Swift SE (2008) MR staging of endometrial cancer: needed or wanted? Cancer Imaging 8:1–5
Manfredi R, Mirk P, Maresca G et al (2004) Local-regional staging of endometrial carcinoma: role of MR imaging in surgical planning. Radiology 231:372–378
Rockall A, Sohaib A, Sala E (2014) Recommendation for cross-sectional imaging in cancer management, 2nd edn. Endoemtrial Cancer. The Royal College of Radiologists, London Available at: https://www.rcr.ac.uk/
Querleu D, Planchamp F, Narducci F et al (2011) Clinical practice guidelines for the management of patients with endometrial cancer in France: recommendations of the Institut National du Cancer and the Société Française d'Oncologie Gynécologique. Int J Gynecol Cancer 21:945–950
Lalwani N, Dubinsky T, Javitt MC et al (2014) ACR Appropriateness Criteria® pretreatment evaluation and follow-up of endometrial cancer. Ultrasound Q 30:21–28
Bonatti M, Stuefer J, Oberhofer N et al (2015) MRI for local staging of endometrial carcinoma: is endovenous contrast medium administration still needed? Eur J Radiol 84:208–214
Das SK, Niu XK, Wang JL et al (2014) Usefulness of DWI in preoperative assessment of deep myometrial invasion in patients with endometrial carcinoma: a systematic review and meta-analysis. Cancer Imaging 14:32
Andreano A, Rechichi G, Rebora P, Sironi S, Valsecchi MG, Galimberti S (2014) MR diffusion imaging for preoperative staging of myometrial invasion in patients with endometrial cancer: a systematic review and meta-analysis. Eur Radiol 24:1327–1338
Duncan KA, Drinkwater KJ, Frost C, Remedios D, Barter S (2012) Staging cancer of the uterus: a national audit of MRI accuracy. Clin Radiol 67:523–530
Luomaranta A, Leminen A, Loukovaara M (2015) Magnetic resonance imaging in the assessment of high-risk features of endometrial carcinoma: a meta-analysis. Int J Gynecol Cancer 25:837–842
Rockall AG, Meroni R, Sohaib SA et al (2007) Evaluation of endometrial carcinoma on magnetic resonance imaging. Int J Gynecol Cancer 17:188–196
Kinkel K, Forstner R, Danza FM et al (2009) Staging of endometrial cancer with MRI: guidelines of the European Society of Urogenital Imaging. Eur Radiol 19:1565–1574
Bazot M, Bharwani N, Huchon C et al (2017) European Society of Urogenital Radiology (ESUR) guidelines: MR imaging of pelvic endometriosis. Eur Radiol 27:2765–2775
Balleyguier C, Sala E, Da Cunha T et al (2011) Staging of uterine cervical cancer with MRI: guidelines of the European Society of Urogenital Radiology. Eur Radiol 21:11002–11110
Funding
The authors state that this work has not received any funding.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Guarantor
The scientific guarantor of this publication is Prof Andrea Rockall.
Conflict of interest
The authors of this manuscript declare no relationships with any companies, whose products or services may be related to the subject matter of the article.
Statistics and biometry
No complex statistical methods were necessary for this paper.
Informed consent
Written informed consent was waived by the institutional review board.
Ethical approval
Institutional review board approval was obtained.
Methodology
• retrospective
• cross-sectional
• multicentre study
Electronic supplementary material
ESM 1
(DOCX 95 kb)
Rights and permissions
About this article
Cite this article
Soneji, N.D., Bharwani, N., Ferri, A. et al. Pre-operative MRI staging of endometrial cancer in a multicentre cancer network: can we match single centre study results?. Eur Radiol 28, 4725–4734 (2018). https://doi.org/10.1007/s00330-018-5465-4
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00330-018-5465-4